Institutional Ownership Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). We have compiled data on the 183 institutions that hold shares in the stock, with a total of 106 Million shares, which have been reported (via 13F filing form) to have a value of $268 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,983,662
shares
|
$36.4 Million
0.0% of portfolio
|
Q2 2024
Added 392.59%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
11,716,829
shares
|
$30.5 Million
0.0% of portfolio
|
Q2 2025
Added 1.99%
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Aug 14, 2025 Q2 2025 |
10,340,261
shares
|
$26.9 Million
0.05% of portfolio
|
Q2 2025
Reduced 5.41%
|
|
Two Seas Capital LP
Rye, NY |
Aug 13, 2025 Q2 2025 |
9,954,975
shares
|
$25.9 Million
0.18% of portfolio
|
Q2 2025
Added 43.63%
|
|
Pender Fund Capital Management Ltd.
Vancouver, A1 |
Aug 14, 2025 Q2 2025 |
6,676,519
shares
|
$17.4 Million
4.26% of portfolio
|
Q2 2025
Added 233.83%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
5,312,252
shares
|
$13.8 Million
0.01% of portfolio
|
Q2 2025
Added 46.22%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
4,583,988
shares
|
$11.9 Million
0.0% of portfolio
|
Q2 2025
Added 3.1%
|
|
Meditor Group LTD
|
Oct 07, 2024 Q3 2024 |
3,791,300
shares
|
$9.86 Million
12.99% of portfolio
|
Q3 2023
Reduced 13.89%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,758,722
shares
|
$9.77 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.36%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,119,253
shares
|
$8.11 Million
0.0% of portfolio
|
Q4 2024
Added 48.61%
|
|
Indaba Capital Management, L.P.
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
3,000,000
shares
|
$7.8 Million
7.03% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,329,133
shares
|
$6.06 Million
0.0% of portfolio
|
Q2 2025
Added 11.38%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
2,093,700
shares
|
$5.44 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.15%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,921,707
shares
|
$5 Million
0.0% of portfolio
|
Q1 2025
Reduced 21.7%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,827,994
shares
|
$4.75 Million
0.0% of portfolio
|
Q2 2025
Reduced 33.07%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,784,126
shares
|
$4.64 Million
0.0% of portfolio
|
Q2 2025
Added 15.93%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,537,212
shares
|
$4 Million
0.0% of portfolio
|
Q2 2025
Added 129.46%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,503,754
shares
|
$3.91 Million
0.01% of portfolio
|
Q1 2025
Added 0.0%
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
1,166,521
shares
|
$3.03 Million
0.0% of portfolio
|
Q2 2025
Added 17375.97%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,055,488
shares
|
$2.74 Million
0.0% of portfolio
|
Q2 2025
Reduced 83.98%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
836,461
shares
|
$2.17 Million
0.0% of portfolio
|
Q2 2025
Added 9.68%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
836,339
shares
|
$2.17 Million
0.0% of portfolio
|
Q2 2025
Reduced 45.24%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
798,754
shares
|
$2.08 Million
0.0% of portfolio
|
Q2 2025
Reduced 47.7%
|
|
Diametric Capital, LP
Boston, MA |
Aug 13, 2025 Q2 2025 |
678,824
shares
|
$1.76 Million
0.44% of portfolio
|
Q2 2025
Added 57.8%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
617,139
shares
|
$1.6 Million
0.0% of portfolio
|
Q2 2025
Added 11.35%
|